Abstract
Porphyrins have been explored as emerging theranostic agents in the therapeutic intervention of cancer. It has been potentially implicated in the treatment of cancer radiotherapy, photodynamic therapy, chemical sonosensitizer, fluorescence magnetic resonance, and other biomedical imaging. Due to the hydrophobic property of porphyrin, it forms insoluble aggregate in aqueous medium and is not easy to work. However, several work has been taken place and isolated new porphyrin but due to the lack of tissue selectivity, high aggregation in skin only few of them has real clinical efficacy. Despite this, encapsulating porphyrin in nanoparticles through rational design make it promising because of transformation into suitable forms such as lipophilic, immune tolerance, prolonged tissue lifetime, and improved delivery features. Additionally the various surface modifying components (viz., ligands, targeting moiety/protein/peptides, and imaging agent) could be introduced into nanoparticulate platforms for cancer theranostics. This chapter briefly acquainted the insight into current porphyrin-based nanoparticles delivery in multimodal imaging and diagnosis of tumor and simultaneous therapeutic utility in pharmaceutical and biomedical sciences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akhter, M. H.. (2017). Multifunctional nanocargo in the treatment modalities in tumor microenvironment. Pharma Focus Asia [cited 2017 April]. Available from: https://www.pharmafocusasia. com/articles/multifunctional-nano-cargo-for-drugdelivery-to-tumor-cells.
Akhter, M. H., Alam, M. S., & Minhaj, M. A.. (2018). Smart nano-enabled drug carrier in combating tumor development and progress. Pharma Focus Asia [cited 2018b September]. Available from: https://www.pharmafocusasia.com/articles/smart-nanoenabled-drug-carrier-in-combating-tumor-development.
Akhter, M. H., & Amin, S. (2017). An investigative approach to the treatment modalities of squamous cell carcinoma. Current Drug Delivery, 14, 597–612.
Akhter, M. H., Beg, S., Tarique, M., Malik, A., Afaq, S., & Choudhry, H. (2020). Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead. Biochimica et Biophysica Acta (BBA) – General Subjects, 1865(2), 129777. Available online 29 October 2020a.
Akhter, M. H., Madhav, N. S., & Ahmad, J. (2018). Epidermal growth factor based active targeting: A paradigm shift towards advance tumor therapy. Artif Cells Nanomed Biotech, 46(2), 1–11.
Akhter, M. H., Nomani, S., & Kumar, S. (2020). Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: Design, optimization, and in vitro studies. Drug Development and Industrial Pharmacy, 46(4), 1–14.
Akhter, M. H., et al. (2020). Molecular targets and nanoparticulate systems designed for the improved therapeutic intervention in glioblastoma multiforme. Drug Research, 71(3), 122–137. Accepted, 19 October, 2020b.
Benov, L. (2015). Photodynamic therapy: Current status and future directions. Medical Principles and Practice, 24, 14–28.
Bera, K., Maiti, S., Maity, M., Mandal, C., & Maiti, N. C. (2018). Porphyrin–gold nanomaterial for efficient drug delivery to cancerous cells. ACS Omega, 3(4), 4602–4619.
Blau, R., Krivitsky, A., Epshtein, Y., & Satchi-Fainaro, R. (2016). Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine? Drug Resistance Updates, 27, 39–58.
Boyer, J.-C., Vetrone, F., Cuccia, L. A., & Capobianco, J. A. (2006). Synthesis of colloidal upconverting NaYF4 nanocrystals doped with Er3+, Yb3+ and Tm3+, Yb3+ via thermal decomposition of lanthanide trifluoroacetate precursors. Journal of the American Chemical Society, 128, 7444.
Cao, Y., Wu, C., Liu, Y., Hu, L., Shang, W., Gao, Z., & Xia, N. (2020). Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721. Drug Delivery, 27(1), 258–268.
Chen, B., Pogue, B. W., & Hasan, T. (2005). Liposomal delivery of photosensitising agents. Expert Opinion on Drug Delivery, 2(3), 477–487.
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017). Rethinking cancer nanotheranostics. Nature Reviews Materials, 2, 17024.
Chen, W., & Zhang, J. (2006). Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. Journal of Nanoscience and Nanotechnology, 6(4), 1159–1166.
Hou, W., Lou, J. W. H., Bu, J., Chang, E., Ding, L., & Valic, M. (2019). Nanoemulsion with porphyrin shell for cancer theranostics. Angewandte Chemie, International Edition, 58(42), 14974–14978.
Hu, S., Trinchi, A., Atkin, P., & Cole, I. (2015). Tunable photoluminescence across the entire visible spectrum from carbon dots excited by white light. Angewandte Chemie, International Edition, 54, 2970–2974.
Hua, K., Yangab, Z., Zhang, L., Xie, L., Wang, L., Xu, H., Lee Josephson, L., Liang, S. H., & Zhang, M.-R. (2020). Boron agents for neutron capture therapy. Coordination Chemistry Reviews, 405, 213139.
Imran, M., Ramzan, M., Qureshi, A. K., Khan, M. A., & Tariq, M. (2018). Emerging applications of porphyrins and Metalloporphyrins in biomedicine and diagnostic magnetic resonance imaging. Biosensors (Basel), 8(4), 95. Published 2018 Oct 19.
Jia, H.-R., Jian, Y.-W., Zhua, Y.-X., Lia, Y.-H., Wang, H.-Y., Han, X., et al. (2017). Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy. Journal of Controlled Release, 255, 231–241.
Jiang, F., Lilge, L., Grenier, J., Li, Y., Wilson, M. D., & Chopp, M. (1998). Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. Laser in Surgery and Medicine, 22(2), 74–80.
Kepczyński, M., Nawalany, K., Jachimska, B., Romek, M., & Nowakowska, M. (2006). Pegylated tetraarylporphyrin entrapped in liposomal membranes. A possible novel drug-carrier system for photodynamic therapy. Colloids and Surfaces. B, Biointerfaces, 49(1), 22–30.
Kievit, F. M., & Zhang, M. (2011). Cancer nanotheranostics: Improving imaging and therapy by targeted delivery across biological barriers. Advanced Materials, 23, H217–H247.
Lee, M. H., Kim, E.-J., Lee, H., Kim, H. M., Chang, M. J., Park, S. Y., Hong, K. S., Kim, J. S., & Sessler, J. L. (2016). Liposomal Texaphyrin Theranostics for metastatic liver cancer. Journal of the American Chemical Society, 138(50), 16380–16387.
Li, Y., Bai, G., Zeng, S., & Hao, J. (2019). Theranostic carbon dots with innovative NIR-II emission for in vivo renal-excreted optical imaging and Photothermal therapy. ACS Applied Materials & Interfaces, 11(5), 4737–4744.
Liu, T. W., MacDonald, T. D., Shi, J., Wilson, B. C., & Zheng, G. (2012). Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angewandte Chemie, International Edition, 51, 13128.
Lovell, J. F., Jin, C. S., Huynh, E., Jin, H., Kim, C., Rubinstein, J. L., Chan, W. C. W., Cao, W., Wang, L. V., & Zheng, G. (2011). Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nature Materials, 10, 324–332.
Nabil, G., Bhise, K., Sau, S., Atef, M., El-Banna, H. A., & Iyer, A. K. (2019). Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation. Drug Discovery Today, 24, 462–491.
Nawalany, K., Rusin, A., Kepczynski, M., Filipczak, P., Kumorek, M., Kozik, B., Weitman, H., Ehrenberg, B., Krawczyk, Z., & Nowakowska, M. (2012, July 1). Novel nanostructural photosensitizers for photodynamic therapy: In vitro studies. International Journal of Pharmaceutics, 430(1–2), 129–140.
Obaid, G., Chambrier, I., Cook, M. J., & Russell, D. A. (2015). Cancer targeting with biomolecules: A comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles. Photochemical & Photobiological Sciences, 14, 737–747.
Paszko, E., Ehrhardt, C., Senge, M. O., Kelleher, D. P., & Reynolds, J. V. (2011). Nanodrug applications in photodynamic therapy. Photodiagnosis and Photodynamic Ther, 8, 14–29.
Qu, S., Wang, X., Lu, Q., Liu, X., & Wang, L. (2012). A biocompatible fluorescent ink based on water-soluble luminescent carbon Nanodots. Angewandte Chemie, International Edition, 51, 12215–12218.
Qu, S., Zhou, D., Li, D., Ji, W., Jing, P., Han, D., Liu, L., Zeng, H., & Shen, D. (2016). Toward efficient orange emissive carbon Nanodots through conjugated sp2 -domain controlling and surface charges engineering. Advanced Materials, 28, 3516–3521.
Renner, M. W., Miura, M., Easson, M. W., & Vicente, M. G. (2006). Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy. Anti-Cancer Agents in Medicinal Chemistry, 6(2), 145–157.
Rieffel, J., Chen, F., Kim, J., Chen, G., Shao, W., Shao, S., et al. (2015). Hexamodal imaging with porphyrin-phospholipid-coated Upconversion nanoparticles. Advanced Materials, 27(10), 1785–1790.
Rizvi, I., Nath, S., Obaid, G., Ruhi, M. K., Moore, K., Bano, S., Kessel, D., & Hasan, T. (2019). A combination of Visudyne and a lipid-anchored liposomal formulation of benzoporphyrin derivative enhances photodynamic therapy efficacy in a 3D model for ovarian cancer. Photochemistry and Photobiology, 95(1), 419–429.
Rosenkranz, A. A., Jans, D. A., & Sobolev, A. S. (2000). Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunology and Cell Biology, 78, 452–464.
Sadzuka, Y., Iwasaki, F., Sugiyama, I., Horiuchi, K., Hirano, T., Ozawa, H., Kanayama, N., & Sonobe, T. (2007). Study on liposomalization of zinc-coproporphyrin I as a novel drug in photodynamic therapy. International Journal of Pharmaceutics, 338(1–2), 306–309.
Schmidt-Erfurth, U., & Hasan, T. (2000). Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Survey of Ophthalmology, 45, 195–214.
Soni, K., Mujtaba, A., Akhter, M. H., et al. (2020). Optimisation of ethosomal nanogel for topical nano-CUR and sulphoraphane delivery in effective skin cancer therapy. Journal of Microencapsulation, 37(2), 91–108.
Takehara, Y., Sakahara, H., Masunaga, H., et al. (2002). Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model. Magnetic Resonance in Medicine, 47(3), 549–553.
Tsolekile, N., Nelana, S., & Oluwafemi, O. S. (2019). Porphyrin as diagnostic and therapeutic agent. Molecules, 24(14), 2669.
Wang, M., & Thanou, M. (2010). Targeting nanoparticles to cancer. Pharmacological Research, 62, 90–99.
Wu, F., Su, H., Cai, Y., Wong, W.-K., Jiang, W., & Zhu, X. (2018). Porphyrin-implanted carbon Nanodots for photoacoustic imaging and in vivo breast Cancer ablation. ACS Applied Bio Materials, 1, 110–117.
Xue, X., Lindstrom, A., & Li, Y. (2019). Porphyrin-based nanomedicines for cancer treatment. Bioconjugate Chemistry, 30(6), 1585–1603.
Yuan, Y., Bo, R., Jing, D., Ma, Z., Wang, Z., Lin, T.-Y., Dong, L., Xue, X., Li, Y., & Vicente, M. G. (2001). Porphyrin-based sensitizers in the detection and treatment of cancer: Recent progress. Current Medicinal Chemistry – Anti-Cancer Agents, 1(2), 175–194.
Zhang, P., Hu, C., Ran, W., Meng, J., Yin, Q., & Li, Y. (2016). Recent progress in light-triggered Nanotheranostics for cancer treatment. Theranostics, 6(7), 948–968.
Zhang, X., Lovejoy, K. S., Jasanoff, A., & Lippard, S. J. (2007). Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proceedings of the National Academy of Sciences of the United States of America, 104(26), 10780–10785.
Zhou, Y., Liang, X., & Dai, Z. (2016). Porphyrin-loaded nanoparticles for cancer theranostic. Nanoscale, 8, 12394–12405.
Zhu, S., Meng, Q., Wang, L., Zhang, J., Song, Y., Jin, H., Zhang, K., Sun, H., Wang, H., & Yang, B. (2013). Highly Photoluminescent carbon dots for multicolor patterning, sensors, and bioimaging. Angewandte Chemie, International Edition, 52, 3953–3957.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akhter, M.H. et al. (2021). Porphyrin-Based Nanomaterials for Cancer Nanotheranostics. In: Saravanan, M., Barabadi, H. (eds) Cancer Nanotheranostics. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-74330-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-74330-7_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74329-1
Online ISBN: 978-3-030-74330-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)